1. Cost-Effectiveness of a Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer 
David Feller-Kopman, MD, Shan Liu, PhD, Benjamin P. Geisler, MD, Malcolm M. DeCamp, MD, Jan B. Pietzsch, PhD 
Journal of Thoracic Oncology 
Volume 12, Issue 8, Pages (August 2017)
DOI: /j.jtho
Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

2. Figure 1
Representation of model structure (simplified). In the classifier strategy, classifier costs were considered only in the case of a nondiagnostic bronchoscopy result. VATS, video-assisted thoracoscopy; f/u: follow-up; TTNA, transthoracic needle aspiration.
Journal of Thoracic Oncology  , DOI: ( /j.jtho )
Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

3. Figure 2
Projected absolute number of invasive procedures per patient for the two competing strategies at 1 month (left) and 2 years (right), and resulting relative reduction in procedures.
Journal of Thoracic Oncology  , DOI: ( /j.jtho )
Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions